Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Resonance Specialities Ltd (RESONANCE) is currently trading at 145.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Resonance Specialities Limited manufactures and markets Pyridine and Pyridine derivatives, Picoline, and Cyanopyridine, serving industries like pharmaceuticals, chemicals, and agro-chemicals. The company's plant is strategically located in the Tarapur Industrial Zone, providing easy access to resources and distribution channels. Significant recent upgrades include tripling production capacities for Cyanopyridines and enhancing technology with a new fluidized reactor to optimize processes. Partnership with Reilly Chemicals S.A. from Belgium has bolstered the company's production capabilities, particularly in plant upgradation. Innovation in operations, such as the addition of new scrubbers and DG capacity, highlights ongoing efficiency improvements.
Over the past 52 weeks, Resonance Specialities Ltd has traded between a low of ₹77.00 and a high of ₹148.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Resonance Specialities Ltd has a market capitalization of approximately 165.60. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Resonance Specialities Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 16.14 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 165.60 Cr, Resonance Specialities Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Resonance Specialities Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Resonance Specialities Ltd is 16.14. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Board Meeting
Resonance Specialities Ltd informed BSE that the Board will meet on 2026-08-04 to consider and approve unaudited Q1 results for quarter ended 30-06-2026. Trading window closed from COB 30-06-2026 until 48 hours after declaration.
Board Meeting
Resonance Specialities Ltd informed BSE that its Board will meet on 2026-08-04 to consider and approve unaudited Q1 results for the quarter ended June 30, 2026; trading window closed from June 30, 2026 until 48 hours after declaration.
Resonance Specialities Limited manufactures and markets Pyridine and Pyridine derivatives, Picoline, and Cyanopyridine, serving industries like pharmaceuticals, chemicals, and agro-chemicals.
The company's plant is strategically located in the Tarapur Industrial Zone, providing easy access to resources and distribution channels.
Significant recent upgrades include tripling production capacities for Cyanopyridines and enhancing technology with a new fluidized reactor to optimize processes.
Partnership with Reilly Chemicals S.A. from Belgium has bolstered the company's production capabilities, particularly in plant upgradation.
Innovation in operations, such as the addition of new scrubbers and DG capacity, highlights ongoing efficiency improvements.
Chemicals & Petrochemicals
Specialty Chemicals
166 Cr
Moderate Risk
16.1
44.1
0.3
2.4
148.00
77.00
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Bearish
8
Neutral
1
Bullish
5
Bearish
8
Neutral
1
Bullish
37
Bearish
0
Neutral
0
Bullish
32
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1.12 | 198 Cr | 56.00 | 0.46 | 0.00 | 0.79 | 2.40 | 0.61 | ||
244.20 | 192 Cr | 12.13 | 1.11 | 3.27 | 9.18 | 13.56 | 5.05 | ||
12.50 | 169 Cr | 11.47 | 1.26 | 0.40 | 10.96 | 12.43 | 6.68 | ||
145.00 | 166 Cr | 16.14 | 2.38 | 0.70 | 14.19 | 18.97 | 11.25 | ||
160.05 | 165 Cr | 8.66 | 1.05 | 0.94 | 11.89 | 14.61 | 5.46 | ||
52.08 | 143 Cr | — | 1.01 | 0.00 | -5.00 | 0.88 | -2.78 | ||
10977.50 | 132 Cr | 27.78 | 1.00 | 0.00 | 3.62 | 6.15 | 2.50 | ||
| Median: 7 Co. | — | 145.00 | 166 Cr | 14.14 | 1.05 | 0.40 | 9.18 | 12.43 | 5.05 |
